Clinical Trials Browser

Phase 2 × Esophageal Diseases × Erlotinib Hydrochloride × Clear all

NCT00442507 2015-07-24

OSI3650

Phase 2 Terminated

6 enrolled 7 charts

Gastrointestinal

Esophageal Diseases, Esophageal Neoplasms